AI-generated summary
The authors studied 20 women with female pattern hair loss (13) or telogen effluvium (7) who received 655 nm low-level laser therapy twice weekly for 16 weeks. They report that hair counts significantly increased in the female pattern hair loss group, with no significant change in the telogen effluvium group and no serious adverse events.
- Participants
- 20
- Who or what was studied
- Women with female pattern hair loss (13) or telogen effluvium (7), Egypt
- Wavelengths
- 655 nm
- Limits stated in the abstract
- The study was small, had no control group, and the authors call for further studies on long-term effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Androgenetic alopecia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.